Enhancer reprogramming in PRC2-deficient malignant peripheral nerve sheath tumors induces a targetable de-differentiated state
Veena Kochat, Ayush T. Raman, Sharon M. Landers, Ming Tang, Jonathan E. Schulz, Christopher Terranova, Jace P. Landry, Angela D. Bhalla, Hannah C. Beird, Chia-Chin Wu, Yingda Jiang, Xizeng Mao, Rossana Lazcano, Swati Gite, Davis R. Ingram, Min Yi, Jianhua Zhang, Emily Z. Keung, Christopher P. Scally, Christina L. Roland, Kelly K. Hunt, Barry W. Feig, P. Andrew Futreal, Patrick Hwu, Wei‐Lien Wang, Alexander J. Lazar, John M. Slopis, Heather Wilson‐Robles, Dominique J. Wiener, Ian E. McCutcheon, Brandan G. Wustefeld‐Janssens, Kunal Rai, Keila E. Torres
Topics & Concepts
ReprogrammingPeripheralPeripheral nervePathologyPRC2Cancer researchMedicineChemistryBiologyEZH2AnatomyInternal medicineCellHistoneDNAGeneticsNeurofibromatosis and Schwannoma CasesNeuroblastoma Research and TreatmentsChromatin Remodeling and Cancer